Literature DB >> 9797602

Linear growth in prepubertal children with atopic dermatitis.

L Patel1, P E Clayton, G M Addison, D A Price, T J David.   

Abstract

OBJECTIVE: To define the evolution of prepubertal growth in atopic dermatitis and the factors influencing that growth pattern.
METHODS: Height and height velocity over two years, weight, triceps and subscapular skin fold thickness, and bone age were assessed in 80 prepubertal patients with atopic dermatitis and a control group of 71 healthy prepubertal school children.
RESULTS: Height standard deviation scores (SDS) and height velocity SDS did not differ between patients and controls, and were not influenced by body surface area affected by atopic dermatitis, topical glucocorticoid potency, or coexisting asthma. However, height SDS (r = -0.37) and height velocity SDS (r = -0.31) correlated inversely to age in patients but not in controls. A greater proportion (z = 2.84) of patients than controls had year 2 height velocity SDS less than -1.96. Patients had a mean delay in bone age of 0.22 years and 0.41 years at the beginning of year 1 and year 2 of the study, respectively. The delay in bone age correlated positively with age (r = 0.39) and duration of atopic dermatitis (r = 0.39), and negatively with height SDS (r = -0.51) and height velocity SDS (r = -0.38).
CONCLUSIONS: Prepubertal children with atopic dermatitis are not short compared with controls. However, as they approach the teenage years their height velocity decreases, the proportion of children with extremely low height velocity increases, and the delay in bone age increases. These features are consistent with the pattern of growth seen in people with constitutional growth delay.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797602      PMCID: PMC1717669          DOI: 10.1136/adc.79.2.169

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

1.  Alternate-day corticosteroid therapy.

Authors:  G H REICHLING; A M KLIGMAN
Journal:  Arch Dermatol       Date:  1961-06

Review 2.  Delayed adolescence.

Authors:  A Prader
Journal:  Clin Endocrinol Metab       Date:  1975-03

3.  Growth and childhood asthma.

Authors:  L Balfour-Lynn
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

4.  A case of growth retardation and cushing's syndrome due to excessive application of betamethasone-17-valerate ointment.

Authors:  B J Vermeer; G F Heremans
Journal:  Dermatologica       Date:  1974

5.  Long term steroid treatment in asthmatic children.

Authors:  J M Smith
Journal:  Ann Allergy       Date:  1965-10

6.  Dwarfism following long-term topical corticosteroid therapy.

Authors:  H H Bode
Journal:  JAMA       Date:  1980 Aug 22-29       Impact factor: 56.272

7.  Maturational delay and temporal growth retardation in asthmatic boys.

Authors:  R Hauspie; C Susanne; F Alexander
Journal:  J Allergy Clin Immunol       Date:  1977-03       Impact factor: 10.793

8.  The effect on growth of childhood asthma.

Authors:  A J Martin; L I Landau; P D Phelan
Journal:  Acta Paediatr Scand       Date:  1981-09

9.  Short stature and delayed skeletal maturation in children with allergic disease.

Authors:  A C Ferguson; A B Murray; W J Tze
Journal:  J Allergy Clin Immunol       Date:  1982-05       Impact factor: 10.793

10.  Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease.

Authors:  M Turpeinen; O P Salo; S Leisti
Journal:  Br J Dermatol       Date:  1986-10       Impact factor: 9.302

View more
  8 in total

1.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

2.  Effect of inhaled glucocorticoids in childhood on adult height.

Authors:  H William Kelly; Alice L Sternberg; Rachel Lescher; Anne L Fuhlbrigge; Paul Williams; Robert S Zeiger; Hengameh H Raissy; Mark L Van Natta; James Tonascia; Robert C Strunk
Journal:  N Engl J Med       Date:  2012-09-03       Impact factor: 91.245

3.  Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Timothy G Berger; Alfons Krol; Amy S Paller; Kathryn Schwarzenberger; James N Bergman; Sarah L Chamlin; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Steven R Feldman; Jon M Hanifin; David J Margolis; Robert A Silverman; Eric L Simpson; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2014-05-09       Impact factor: 11.527

4.  World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.

Authors:  Alessandro Fiocchi; Jan Brozek; Holger Schünemann; Sami L Bahna; Andrea von Berg; Kirsten Beyer; Martin Bozzola; Julia Bradsher; Enrico Compalati; Motohiro Ebisawa; Maria Antonieta Guzman; Haiqi Li; Ralf G Heine; Paul Keith; Gideon Lack; Massimo Landi; Alberto Martelli; Fabienne Rancé; Hugh Sampson; Airton Stein; Luigi Terracciano; Stefan Vieths
Journal:  World Allergy Organ J       Date:  2010-04-23       Impact factor: 4.084

Review 5.  Growth and nutritional concerns in children with food allergy.

Authors:  Harshna Mehta; Marion Groetch; Julie Wang
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-06

6.  Does Use of Inhaled Corticosteroid for Management of Asthma in Children Make Them Shorter Adults?

Authors:  Hengameh H Raissy; Kathryn Blake
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2013-06       Impact factor: 1.349

7.  Nutrient intakes of infants with atopic dermatitis and relationship with feeding type.

Authors:  Youngshin Han; Youngmi Lee; Haeryun Park; Sunyoung Park; Kyunghee Song
Journal:  Nutr Res Pract       Date:  2015-01-05       Impact factor: 1.926

8.  Phase 2, randomized, double-blind, placebo-controlled, 4-week study to evaluate the safety and efficacy of OPA- 15406 (difamilast), a new topical selective phosphodiesterase type-4 inhibitor, in Japanese pediatric patients aged 2-14 years with atopic dermatitis.

Authors:  Hidehisa Saeki; Naoko Baba; Kazuhide Oshiden; Yuji Abe; Hidetsugu Tsubouchi
Journal:  J Dermatol       Date:  2019-11-11       Impact factor: 4.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.